Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono

Obstructive slee apnoea (OSA) is a common sleep disorder. It has been recognized a link between OSA and depression , which is most of the times resistant to treatment. Other aspects of OSA are metabolic: insulin resistance, hypertension and obesity. A common treatment for OSA is Continuous Positive...

Full description

Bibliographic Details
Main Author: Margarida Lobo
Format: Article
Language:English
Published: Hospital Prof. Doutor Fernando Fonseca 2014-10-01
Series:PsiLogos
Subjects:
Online Access:https://revistas.rcaap.pt/psilogos/article/view/6045
id doaj-8c54faf0d5c8400dad6fd550af22f7e9
record_format Article
spelling doaj-8c54faf0d5c8400dad6fd550af22f7e92021-06-17T14:17:10ZengHospital Prof. Doutor Fernando FonsecaPsiLogos1646-091X2182-31462014-10-01314617Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do SonoMargarida Lobo0Hospital Nª Senhora do Rosário, EPE (Barreiro)Obstructive slee apnoea (OSA) is a common sleep disorder. It has been recognized a link between OSA and depression , which is most of the times resistant to treatment. Other aspects of OSA are metabolic: insulin resistance, hypertension and obesity. A common treatment for OSA is Continuous Positive Airway Pressure (CPAP). This treatment may reverse the cognitive and affective dysfunction but in some cases with residual impairment. The author reports a case of a 48 years old man with family history of bipolar disorder but no past history of psychiatric disorders. A diagnosis of OSA led to the use of CPAP. Ten days later he started hypomanic symptoms and 15 days later he was strongly manic. He was hospitalized and treated with olanzapine, lorazepam and divalproate. CPAP treatment was interrupted. After recovery the patient became depressed and, since then, although he doesn't meet the criteria for major depression, depressive symptoms persisted even with olanzapine and lamotrigibne. Meanwhile he was diagnosed with diabettes mellitus 2 and olanzapine was discontinued and he was put on ziprasidone. The author discusses the contribution of the OSA and treatment with CPAC to the appearance and maintenance of the affective disorder in a patient with family susceptibility. The discussion also includes the metabolic aspects of OSA that can be worsened with the medication to control the affective disorder.https://revistas.rcaap.pt/psilogos/article/view/6045maniaobstructive sleep apneacontinuous positive airway pressureCPAPmetabolic syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Margarida Lobo
spellingShingle Margarida Lobo
Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono
PsiLogos
mania
obstructive sleep apnea
continuous positive airway pressure
CPAP
metabolic syndrome
author_facet Margarida Lobo
author_sort Margarida Lobo
title Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono
title_short Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono
title_full Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono
title_fullStr Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono
title_full_unstemmed Um Caso de Mania após Tratamento com CPAP em Doente com Apneia Obstrutiva do Sono
title_sort um caso de mania após tratamento com cpap em doente com apneia obstrutiva do sono
publisher Hospital Prof. Doutor Fernando Fonseca
series PsiLogos
issn 1646-091X
2182-3146
publishDate 2014-10-01
description Obstructive slee apnoea (OSA) is a common sleep disorder. It has been recognized a link between OSA and depression , which is most of the times resistant to treatment. Other aspects of OSA are metabolic: insulin resistance, hypertension and obesity. A common treatment for OSA is Continuous Positive Airway Pressure (CPAP). This treatment may reverse the cognitive and affective dysfunction but in some cases with residual impairment. The author reports a case of a 48 years old man with family history of bipolar disorder but no past history of psychiatric disorders. A diagnosis of OSA led to the use of CPAP. Ten days later he started hypomanic symptoms and 15 days later he was strongly manic. He was hospitalized and treated with olanzapine, lorazepam and divalproate. CPAP treatment was interrupted. After recovery the patient became depressed and, since then, although he doesn't meet the criteria for major depression, depressive symptoms persisted even with olanzapine and lamotrigibne. Meanwhile he was diagnosed with diabettes mellitus 2 and olanzapine was discontinued and he was put on ziprasidone. The author discusses the contribution of the OSA and treatment with CPAC to the appearance and maintenance of the affective disorder in a patient with family susceptibility. The discussion also includes the metabolic aspects of OSA that can be worsened with the medication to control the affective disorder.
topic mania
obstructive sleep apnea
continuous positive airway pressure
CPAP
metabolic syndrome
url https://revistas.rcaap.pt/psilogos/article/view/6045
work_keys_str_mv AT margaridalobo umcasodemaniaapostratamentocomcpapemdoentecomapneiaobstrutivadosono
_version_ 1721373849348472832